Display options
Share it on

Metabolites. 2019 Feb 21;9(2). doi: 10.3390/metabo9020036.

Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma.

Metabolites

Shangfu Li, Dan Gao, Yuyang Jiang

Affiliations

  1. State Key Laboratory of Chemical Oncogenomics, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. [email protected].
  2. National & Local United Engineering Lab for Personalized Anti-tumour Drugs, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. [email protected].
  3. State Key Laboratory of Chemical Oncogenomics, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. [email protected].
  4. National & Local United Engineering Lab for Personalized Anti-tumour Drugs, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. [email protected].
  5. Key Laboratory of Metabolomics at Shenzhen, Shenzhen 518055, China. [email protected].
  6. State Key Laboratory of Chemical Oncogenomics, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. [email protected].
  7. School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China. [email protected].

PMID: 30795537 PMCID: PMC6410233 DOI: 10.3390/metabo9020036

Abstract

Acylcarnitines play an essential role in regulating the balance of intracellular sugar and lipid metabolism. They serve as carriers to transport activated long-chain fatty acids into mitochondria for β-oxidation as a major source of energy for cell activities. The liver is the most important organ for endogenous carnitine synthesis and metabolism. Hepatocellular carcinoma (HCC), a primary malignancy of the live with poor prognosis, may strongly influence the level of acylcarnitines. In this paper, the function, detection and alteration of acylcarnitine metabolism in HCC were briefly reviewed. An overview was provided to introduce the metabolic roles of acylcarnitines involved in fatty acid β-oxidation. Then different analytical platforms and methodologies were also briefly summarised. The relationship between HCC and acylcarnitine metabolism was described. Many of the studies reported that short, medium and long-chain acylcarnitines were altered in HCC patients. These findings presented current evidence in support of acylcarnitines as new candidate biomarkers for studies on the pathogenesis and development of HCC. Finally we discussed the challenges and perspectives of exploiting acylcarnitine metabolism and its related metabolic pathways as a target for HCC diagnosis and prognosis.

Keywords: acylcarnitines; hepatocellular carcinoma; metabolite profiling; metabolomics

References

  1. J Inherit Metab Dis. 1999 Apr;22(2):201-2 - PubMed
  2. Xenobiotica. 1999 Nov;29(11):1181-9 - PubMed
  3. J Chromatogr B Biomed Sci Appl. 1999 Dec 10;735(2):171-88 - PubMed
  4. Clin Biochem. 2000 Mar;33(2):151-5 - PubMed
  5. Gut. 2000 Jul;47(1):131-6 - PubMed
  6. J Chromatogr A. 2000 Oct 20;895(1-2):309-16 - PubMed
  7. Plant Mol Biol. 2002 Jan;48(1-2):155-71 - PubMed
  8. Rapid Commun Mass Spectrom. 2004;18(11):1233-8 - PubMed
  9. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 5;827(2):193-8 - PubMed
  10. J Lipid Res. 2006 Feb;47(2):431-9 - PubMed
  11. Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78 - PubMed
  12. Rapid Commun Mass Spectrom. 2007;21(5):799-806 - PubMed
  13. Gastroenterology. 2007 Jun;132(7):2557-76 - PubMed
  14. Arch Pharm Res. 2007 Aug;30(8):1041-6 - PubMed
  15. Clin Chem. 2008 Apr;54(4):657-64 - PubMed
  16. Mol Biosyst. 2009 Aug;5(8):868-76 - PubMed
  17. Anal Chim Acta. 2009 Sep 14;650(1):3-9 - PubMed
  18. J Proteome Res. 2010 Feb 5;9(2):1096-103 - PubMed
  19. Nutr Metab (Lond). 2010 Apr 16;7:30 - PubMed
  20. Metabolism. 2011 Mar;60(3):404-13 - PubMed
  21. Hepatology. 2010 May;51(5):1820-32 - PubMed
  22. J Chromatogr Sci. 2010 May-Jun;48(5):371-4 - PubMed
  23. Anal Chem. 2010 Nov 15;82(22):9543-8 - PubMed
  24. J Proteome Res. 2011 Apr 1;10(4):1828-36 - PubMed
  25. Anal Chim Acta. 2011 Mar 9;689(1):77-84 - PubMed
  26. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  27. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Apr 15;879(13-14):921-6 - PubMed
  28. Mol Cell Proteomics. 2011 Jul;10(7):M110.004945 - PubMed
  29. Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):341-52 - PubMed
  30. Science. 2011 Jun 24;332(6037):1519-23 - PubMed
  31. Int J Cancer. 2012 Jun 15;130(12):2791-800 - PubMed
  32. Biochem Pharmacol. 2011 Dec 1;82(11):1549-61 - PubMed
  33. J Sep Sci. 2011 Nov;34(21):3029-36 - PubMed
  34. Mol Cell Proteomics. 2012 Feb;11(2):M111.010694 - PubMed
  35. J Hepatol. 2012 Jun;56(6):1384-91 - PubMed
  36. Anal Bioanal Chem. 2012 Apr;403(1):203-13 - PubMed
  37. Gastroenterology. 2012 May;142(6):1279-1287.e3 - PubMed
  38. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 1;910:149-55 - PubMed
  39. J Lipid Res. 2013 Feb;54(2):333-44 - PubMed
  40. J Proteome Res. 2012 Nov 2;11(11):5433-42 - PubMed
  41. J Proteome Res. 2012 Dec 7;11(12):5914-23 - PubMed
  42. Hepatology. 2013 May;57(5):2072-7 - PubMed
  43. Nucleic Acids Res. 2013 Jan;41(Database issue):D801-7 - PubMed
  44. J Chromatogr A. 2013 May 31;1292:189-94 - PubMed
  45. World J Gastroenterol. 2013 Jun 14;19(22):3423-32 - PubMed
  46. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:12-8 - PubMed
  47. Cancer Res. 2013 Aug 15;73(16):4992-5002 - PubMed
  48. Electrophoresis. 2013 Oct;34(19):2910-7 - PubMed
  49. Anal Chem. 2013 Sep 3;85(17):8326-33 - PubMed
  50. Antioxid Redox Signal. 2014 Aug 1;21(4):588-600 - PubMed
  51. Anal Bioanal Chem. 2013 Nov;405(27):8829-36 - PubMed
  52. Biomed Chromatogr. 2013 Oct;27(10):1339-53 - PubMed
  53. Clin Chim Acta. 2014 Feb 15;429:30-3 - PubMed
  54. Int J Cancer. 2014 Aug 1;135(3):658-68 - PubMed
  55. Dig Liver Dis. 2014 May;46(5):427-32 - PubMed
  56. Liver Int. 2014 Oct;34(9):1428-44 - PubMed
  57. Compr Physiol. 2014 Jan;4(1):177-97 - PubMed
  58. Anal Chem. 2014 Aug 19;86(16):8048-56 - PubMed
  59. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 1;966:100-8 - PubMed
  60. PLoS One. 2014 Jul 01;9(7):e100627 - PubMed
  61. J Proteome Res. 2015 Feb 6;14(2):906-16 - PubMed
  62. J Pharm Biomed Anal. 2015 May 10;109:171-6 - PubMed
  63. Br J Cancer. 2015 Mar 31;112(7):1141-56 - PubMed
  64. Cancer Res. 2015 Jun 15;75(12):2541-52 - PubMed
  65. Mol Neurobiol. 2015 Oct;52(2):826-36 - PubMed
  66. Cell Metab. 2015 Jul 7;22(1):65-76 - PubMed
  67. J Lipid Res. 2015 Oct;56(10):2029-39 - PubMed
  68. Anal Chem. 2015 Sep 1;87(17):8994-9001 - PubMed
  69. Nat Rev Endocrinol. 2015 Oct;11(10):617-25 - PubMed
  70. Hepatobiliary Surg Nutr. 2015 Aug;4(4):293-4 - PubMed
  71. World J Hepatol. 2015 Aug 28;7(18):2155-61 - PubMed
  72. PLoS Genet. 2015 Sep 24;11(9):e1005510 - PubMed
  73. Bioorg Med Chem Lett. 2016 Jan 1;26(1):121-5 - PubMed
  74. Mediators Inflamm. 2015;2015:608216 - PubMed
  75. Prog Lipid Res. 2016 Jan;61:134-48 - PubMed
  76. J Am Coll Cardiol. 2016 Jan 26;67(3):291-9 - PubMed
  77. Sci Rep. 2016 Feb 02;6:20299 - PubMed
  78. PLoS One. 2016 Feb 16;11(2):e0147818 - PubMed
  79. World J Gastroenterol. 2016 Feb 28;22(8):2494-502 - PubMed
  80. Cancer Res. 2016 May 15;76(10):2912-20 - PubMed
  81. Mol Biosyst. 2016 Apr 26;12(5):1496-506 - PubMed
  82. Am J Clin Nutr. 2016 Jun;103(6):1408-16 - PubMed
  83. Biochim Biophys Acta. 2016 Aug;1862(8):1375-82 - PubMed
  84. World J Gastroenterol. 2016 Apr 28;22(16):4191-200 - PubMed
  85. Biomed Chromatogr. 2016 Nov;30(11):1796-1806 - PubMed
  86. Cell Death Dis. 2016 May 19;7:e2226 - PubMed
  87. Diabetes Care. 2016 Sep;39(9):1563-70 - PubMed
  88. J Am Heart Assoc. 2017 Feb 3;6(2): - PubMed
  89. Mol Genet Metab. 2017 Apr;120(4):363-369 - PubMed
  90. Sci Rep. 2017 Feb 15;7:42710 - PubMed
  91. J Hepatol. 2017 Sep;67(3):603-618 - PubMed
  92. Anal Chem. 2017 Aug 1;89(15):8112-8121 - PubMed
  93. Oncogene. 2017 Oct 26;36(43):6030-6040 - PubMed
  94. Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H768-H781 - PubMed
  95. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 1;1061-1062:128-133 - PubMed
  96. J Proteome Res. 2017 Oct 6;16(10):3558-3566 - PubMed
  97. Anal Chem. 2017 Oct 3;89(19):10368-10375 - PubMed
  98. Cell Metab. 2017 Sep 5;26(3):509-522.e6 - PubMed
  99. Am J Hum Genet. 2017 Oct 5;101(4):489-502 - PubMed
  100. Histol Histopathol. 2018 Apr;33(4):343-355 - PubMed
  101. Oncotarget. 2017 Jul 10;8(38):63890-63900 - PubMed
  102. J Hepatol. 2018 Mar;68(3):526-549 - PubMed
  103. Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617 - PubMed
  104. J Viral Hepat. 2018 May;25(5):473-481 - PubMed
  105. Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):607-617 - PubMed
  106. Sci Rep. 2017 Dec 13;7(1):17528 - PubMed
  107. Cell Death Differ. 2018 Mar;25(4):733-746 - PubMed
  108. Diabetes. 2018 May;67(5):885-897 - PubMed
  109. Gut. 2018 Aug;67(8):1493-1504 - PubMed
  110. Cell Death Dis. 2018 Feb 14;9(2):228 - PubMed
  111. Sci Rep. 2018 Feb 19;8(1):3254 - PubMed
  112. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):560-568 - PubMed
  113. Trends Mol Med. 2018 Apr;24(4):395-411 - PubMed
  114. Food Res Int. 2018 May;107:346-352 - PubMed
  115. Anal Chem. 2018 May 1;90(9):5712-5718 - PubMed
  116. Cancer Manag Res. 2018 Apr 11;10:715-734 - PubMed
  117. J Viral Hepat. 2018 Oct;25(10):1172-1179 - PubMed
  118. Onco Targets Ther. 2018 May 25;11:3101-3110 - PubMed
  119. NPJ Precis Oncol. 2018 Feb 23;2(1):6 - PubMed
  120. Cell Physiol Biochem. 2018;48(2):491-502 - PubMed
  121. Mol Genet Metab. 2018 Sep;125(1-2):144-152 - PubMed
  122. J Adv Res. 2018 Apr 25;12:55-66 - PubMed
  123. Arch Med Res. 2018 Apr;49(3):205-212 - PubMed
  124. Dig Liver Dis. 2018 Nov;50(11):1115-1123 - PubMed
  125. Gastroenterology. 2019 Jan;156(2):338-354 - PubMed
  126. Anal Chim Acta. 2018 Dec 11;1037:177-187 - PubMed
  127. Cancers (Basel). 2018 Nov 15;10(11):null - PubMed
  128. Mol Carcinog. 2019 Jan 3;:null - PubMed
  129. J Biol Chem. 1984 Jul 25;259(14):9082-9 - PubMed
  130. Biochim Biophys Acta. 1994 Jul 18;1226(3):269-76 - PubMed
  131. Hepatology. 1997 Jan;25(1):148-53 - PubMed
  132. J Lipid Res. 1997 Jan;38(1):173-82 - PubMed

Publication Types

Grant support